ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,077,523 | +23.8% | 65,105 | +7.5% | 0.03% | +17.2% |
Q1 2024 | $4,102,214 | -0.3% | 60,550 | -0.9% | 0.03% | -9.4% |
Q4 2023 | $4,113,333 | -6.5% | 61,074 | -6.0% | 0.03% | -17.9% |
Q3 2023 | $4,399,140 | -11.7% | 64,961 | -6.6% | 0.04% | -9.3% |
Q2 2023 | $4,982,179 | -0.1% | 69,523 | -3.3% | 0.04% | -10.4% |
Q1 2023 | $4,987,896 | +45.6% | 71,862 | +2.4% | 0.05% | -72.1% |
Q4 2022 | $3,424,931 | -9.0% | 70,202 | +2.3% | 0.17% | +300.0% |
Q3 2022 | $3,764,000 | -44.1% | 68,645 | -32.7% | 0.04% | -28.3% |
Q2 2022 | $6,737,000 | +2.3% | 101,974 | +2.8% | 0.06% | +20.0% |
Q1 2022 | $6,583,000 | +17.0% | 99,223 | +2.7% | 0.05% | +19.0% |
Q4 2021 | $5,626,000 | -45.0% | 96,581 | -43.3% | 0.04% | -35.4% |
Q3 2021 | $10,225,000 | +106.1% | 170,251 | +105.5% | 0.06% | +51.2% |
Q2 2021 | $4,962,000 | +20.6% | 82,833 | +0.1% | 0.04% | +10.3% |
Q1 2021 | $4,114,000 | +104.1% | 82,749 | +105.3% | 0.04% | +85.7% |
Q4 2020 | $2,016,000 | +17.4% | 40,314 | +26.6% | 0.02% | -4.5% |
Q3 2020 | $1,717,000 | +12.6% | 31,847 | +10.4% | 0.02% | +4.8% |
Q2 2020 | $1,525,000 | +26.1% | 28,837 | +6.5% | 0.02% | -4.5% |
Q1 2020 | $1,209,000 | -4.4% | 27,081 | +6.7% | 0.02% | +10.0% |
Q4 2019 | $1,265,000 | -43.1% | 25,388 | -46.9% | 0.02% | -42.9% |
Q3 2019 | $2,225,000 | +27.7% | 47,773 | +10.5% | 0.04% | +12.9% |
Q2 2019 | $1,742,000 | +58.2% | 43,251 | +58.7% | 0.03% | +40.9% |
Q1 2019 | $1,101,000 | +38.5% | 27,247 | +30.2% | 0.02% | +15.8% |
Q4 2018 | $795,000 | -39.2% | 20,926 | -36.7% | 0.02% | -29.6% |
Q3 2018 | $1,308,000 | -42.1% | 33,057 | -48.7% | 0.03% | -27.0% |
Q2 2018 | $2,258,000 | +258.4% | 64,479 | +257.9% | 0.04% | +48.0% |
Q1 2018 | $630,000 | -65.7% | 18,015 | -65.4% | 0.02% | -67.9% |
Q4 2017 | $1,835,000 | +35.6% | 52,071 | +32.5% | 0.08% | +136.4% |
Q3 2017 | $1,353,000 | +24.0% | 39,294 | +21.2% | 0.03% | +10.0% |
Q2 2017 | $1,091,000 | -34.4% | 32,426 | -47.0% | 0.03% | -36.2% |
Q1 2017 | $1,663,000 | +146.7% | 61,228 | +155.4% | 0.05% | +113.6% |
Q4 2016 | $674,000 | +19.3% | 23,977 | +38.5% | 0.02% | -4.3% |
Q3 2016 | $565,000 | +0.2% | 17,308 | -7.7% | 0.02% | 0.0% |
Q2 2016 | $564,000 | +24.8% | 18,743 | +16.7% | 0.02% | +4.5% |
Q1 2016 | $452,000 | -25.2% | 16,056 | -9.8% | 0.02% | -24.1% |
Q4 2015 | $604,000 | +20.8% | 17,800 | +13.3% | 0.03% | +7.4% |
Q3 2015 | $500,000 | +1.2% | 15,710 | +102.6% | 0.03% | +17.4% |
Q2 2015 | $494,000 | -4.8% | 7,753 | +2.2% | 0.02% | -23.3% |
Q1 2015 | $519,000 | -6.5% | 7,587 | -3.8% | 0.03% | -16.7% |
Q4 2014 | $555,000 | -35.7% | 7,883 | -34.7% | 0.04% | -40.0% |
Q3 2014 | $863,000 | -3.8% | 12,077 | +0.1% | 0.06% | -22.1% |
Q2 2014 | $897,000 | +9.4% | 12,067 | -4.6% | 0.08% | -10.5% |
Q1 2014 | $820,000 | +5.5% | 12,645 | -3.4% | 0.09% | -1.1% |
Q4 2013 | $777,000 | – | 13,090 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |